文献速递临床试验与 GCP流行病学与生物统计真实世界研究与卫生经济

乌莫约母婴配对模式对赞比亚HIV阳性母亲社会支持、感知污名及其所生HIV暴露婴儿12个月留治的影响:整群随机对照试验证据

Impact of the Umoyo mother-infant pair model on HIV-positive mothers' social support, perceived stigma and 12-month retention of their HIV-exposed infants in PMTCT care: evidence from a cluster randomized controlled trial in Zambia.
PubMed 文献 · Trials · 2019-08-15

在赞比亚两省28家提供预防母婴传播服务的机构开展整群随机对照试验,评估乌莫约母婴配对模式(专设 clinic 日仅服务HIV暴露婴儿及其母亲)对12个月留治的影响。结果显示该模式对12个月留治无影响(-11%;99%CI -40.1%, 17.2%),但敏感性分析提示可提高社会支持(0.31;99%CI 0.08, 0.54)并降低对医护人员的感知污名(-0.27;99%CI -0.46, -0.08)。作者认为该模式单独不足以有效提高HIV暴露婴儿留治。

要点

  • 乌莫约模式对HIV暴露婴儿12个月留治无影响(-11%;99%CI -40.1%, 17.2%)。
  • 敏感性分析提示乌莫约可提高母亲社会支持(0.31;99%CI 0.08, 0.54)。
  • 敏感性分析提示乌莫约可降低对医护人员的感知污名(-0.27;99%CI -0.46, -0.08)。

核心结论

  • 乌莫约专设 clinic 日模式未改善HIV暴露婴儿12个月留治,但有迹象表明可提高母亲社会支持并降低污名。
  • 基于本评估证据,在缺乏对 underlying 卫生系统进一步支持的情况下,乌莫约 clinic 日方法本身不被认为是提高HIV暴露婴儿留治的有效干预。

研究设计与样本

  • 在赞比亚两省28家提供预防母婴传播服务且由同一实施伙伴支持的机构开展整群随机对照试验。
  • 采用协变量约束优化技术进行随机化。
  • 主要结局为HIV暴露婴儿12个月留治;次要结局包括乌莫约诊所对母亲社会支持和感知HIV污名的影响。
  • 每个结局均在机构层面采用非加权t检验进行双重差分分析。

主要发现

  • 13家对照机构12个月留治率(终点)为45%,11家干预机构为33%。
  • t检验显示乌莫约诊所对HIV暴露婴儿12个月留治无影响(-11%;99%CI -40.1%, 17.2%)。
  • 非加权t检验显示对社会支持和污名无影响,但敏感性检验显示乌莫约可提高社会支持(0.31;99%CI 0.08, 0.54)。
  • 敏感性检验显示乌莫约可降低对医护人员的感知污名(-0.27;99%CI -0.46, -0.08)。

关键数值与推荐

  • 12个月留治率:对照机构45% vs 干预机构33%(干预较对照降低11%,99%CI -40.1%, 17.2%)。
  • 社会支持变化:0.31(99%CI 0.08, 0.54),仅见于敏感性检验。
  • 对医护人员感知污名变化:-0.27(99%CI -0.46, -0.08),仅见于敏感性检验。

临床怎么用

  • 作者认为,在缺乏对 underlying 卫生系统进一步支持的情况下,乌莫约 clinic 日方法本身不被认为是提高HIV暴露婴儿留治的有效干预。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Public health systems in resource-constrained settings have a critical role to play in the elimination of HIV transmission but are often financially constrained. This study is an evaluation of a mother-infant-pair model called "Umoyo," which was designed to be low cost and scalable in a public health system. Facilities with the Umoyo model dedicate a clinic day to provide services to only HIV-exposed infants (HEIs) and their mothers. Such models are in operation with reported success in Zambia but have not been rigorously tested. This work establishes whether the Umoyo model would improve 12-month retention of HEIs. METHODS: A cluster randomized trial including 28 facilities was conducted across two provinces of Zambia to investigate the impact on 12-month retention of HEIs in care. These facilities were offering Prevention of Mother-to-Child-Transmission (PMTCT) services and supported by the same implementing partner. Randomization was achieved by use of the covariate-constrained optimization technique. Secondary outcomes included the impact of Umoyo clinics on social support and perceived HIV stigma among mothers. For each of the outcomes, a difference-in-difference analysis was conducted at the facility level using the unweighted t test. RESULTS: From 13 control (12-month retention at endline: 45%) and 11 intervention facilities (12-month retention at endline: 33%), it was found that Umoyo clinics had no impact on 12-month retention of HEIs in the t test (- 11%; 99% CI - 40.1%, 17.2%). Regarding social support and stigma, the un-weighted t test showed no impact though sensitivity tests showed that Umoyo had an impact on increasing social support (0.31; 99% CI 0.08, 0.54) and reducing perceived stigma from health care workers (- 0.27; 99% CI - 0.46, - 0.08). CONCLUSION: The Umoyo approach of having a dedicated clinic day for HEIs and their mothers did not improve retention of HEIs though there are indications that it can increase social support among mothers and reduce stigma. Without further support to the underlying health system, based on the evidence generated through this evaluation, the Umoyo clinic day approach on its own is not considered an effective intervention to increase retention of HIV-exposed infants. TRIAL REGISTRATION: Pan African Clinical Trial Registry, ID: PACTR201702001970148 . Prospectively registered on 13 January 2017.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Phiri SC, Mudhune S, Prust ML, et al. Impact of the Umoyo mother-infant pair model on HIV-positive mothers' social support, perceived stigma and 12-month retention of their HIV-exposed infants in PMTCT care: evidence from a cluster randomized controlled trial in Zambia. Trials. 2019. PMID: 31416459. doi:10.1186/s13063-019-3617-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。